Literature DB >> 26355249

Cognitive Function in Patients With Chronic Kidney Disease: Challenges in Neuropsychological Assessments.

Sabrina M Schneider1, Jan T Kielstein2, Jennifer Braverman3, Marta Novak4.   

Abstract

Cognitive dysfunction is a common symptom in patients with chronic kidney disease (CKD). In this review, we highlight the clinical relevance of cognitive impairment in patients with CKD. After a summary of the different pathophysiological components of this frequently overlooked clinical condition, we summarize and evaluate the available neurocognitive tests and reflect on their utility in everyday clinical practice. Finally, we identify future areas of research and allude to the fact that inclusion of cognitive function testing in routine clinical care of patients with CKD could be cost effective by reducing nonadherence to medication and improving quality of life, and even survival.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cognitive impairment; chronic kidney disease; cognitive dysfunction; dialysis; neuropsychological testing

Mesh:

Year:  2015        PMID: 26355249     DOI: 10.1016/j.semnephrol.2015.06.002

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  12 in total

1.  Cognitive Testing in Patients with CKD: The Problem of Missing Cases.

Authors:  Denise Neumann; Maxi Robinski; Wilfried Mau; Matthias Girndt
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-01       Impact factor: 8.237

Review 2.  The assessment of cognitive function in older adult patients with chronic kidney disease: an integrative review.

Authors:  Mary Hannan; Alana Steffen; Lauretta Quinn; Eileen G Collins; Shane A Phillips; Ulf G Bronas
Journal:  J Nephrol       Date:  2018-05-25       Impact factor: 3.902

3.  Oxidative stress in the brain caused by acute kidney injury.

Authors:  Alexandra Kovalčíková; Marianna Gyurászová; Diana Vavrincová-Yaghi; Peter Vavrinec; Ľubomíra Tóthová; Peter Boor; Katarína Šebeková; Peter Celec
Journal:  Metab Brain Dis       Date:  2018-03-07       Impact factor: 3.584

4.  The Utility of the Mini-Addenbrooke's Cognitive Examination as a Screen for Cognitive Impairment in Elderly Patients with Chronic Kidney Disease and Diabetes.

Authors:  Peter Hobson; Kamel H Rohoma; Stephen P Wong; Mick J Kumwenda
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2016-12-05

5.  Cognitive Impairment and Associated Factors Among Chronic Kidney Disease Patients: A Comparative Cross-Sectional Study.

Authors:  Yibeltal Yismaw Gela; Ayechew Adera Getu; Aynishet Adane; Bezawit Mulat Ayal; Yonas Akalu; Adugnaw Ambelu; Mengistie Diress; Yigizie Yeshaw
Journal:  Neuropsychiatr Dis Treat       Date:  2021-05-17       Impact factor: 2.570

Review 6.  Role of Vitamin D in Cognitive Function in Chronic Kidney Disease.

Authors:  Zhen Cheng; Jing Lin; Qi Qian
Journal:  Nutrients       Date:  2016-05-13       Impact factor: 5.717

7.  Plasma brain-derived neurotrophic factor concentration is a predictor of chronic kidney disease in patients with cardiovascular risk factors - Hyogo Sleep Cardio-Autonomic Atherosclerosis study.

Authors:  Masafumi Kurajoh; Manabu Kadoya; Akiko Morimoto; Akio Miyoshi; Akinori Kanzaki; Miki Kakutani-Hatayama; Kae Hamamoto; Takuhito Shoji; Yuji Moriwaki; Tetsuya Yamamoto; Masaaki Inaba; Mitsuyoshi Namba; Hidenori Koyama
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

8.  COGNITOMICS: a new approach for the evaluation of the relationship between diseases and cognition to be designed based on normal behavioral tendencies in real life, a conceptual framework.

Authors:  Ata Pourabbasi; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2017-05-15

9.  Executive function in end-stage renal disease: Acute effects of hemodialysis and associations with clinical factors.

Authors:  María Del Mar Sánchez-Fernández; Gustavo A Reyes Del Paso; José Manuel Gil-Cunquero; María José Fernández-Serrano
Journal:  PLoS One       Date:  2018-09-04       Impact factor: 3.240

10.  AST-120 Reduces Neuroinflammation Induced by Indoxyl Sulfate in Glial Cells.

Authors:  Simona Adesso; Irene Paterniti; Salvatore Cuzzocrea; Masaki Fujioka; Giuseppina Autore; Tim Magnus; Aldo Pinto; Stefania Marzocco
Journal:  J Clin Med       Date:  2018-10-17       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.